Sam Chun Dang Pharm. Co., Ltd

KOSDAQ:A000250 株式レポート

時価総額：₩4.8t

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Sam Chun Dang Pharm マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Dae-In Yoon

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権7.1%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Subdued Growth No Barrier To Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) With Shares Advancing 44%

Jun 19
Subdued Growth No Barrier To Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) With Shares Advancing 44%

Is Sam Chun Dang Pharm (KOSDAQ:000250) A Risky Investment?

Jun 09
Is Sam Chun Dang Pharm (KOSDAQ:000250) A Risky Investment?

Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking

Mar 21
Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking

Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly

Feb 26
Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly

Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%

Feb 09
Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%

Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?

Jan 05
Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?

Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly

Dec 01
Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly

CEO（最高経営責任者

Dae-In Yoon (74 yo)

no data

在職期間

Dae-In Yoon serves as the Chief Executive Officer and Chairman of Sam Chun Dang Pharmacy. Dae-In Yoon serves as Chief Executive Officer and Chairperson of Sam Chun Dang Pharm Co. Ltd. Dae-In Yoon serves as...